PR Newswire BOSTON, March 4, 2026 BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid ® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid(R) Narrow Anchor, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results